Pharmaceutical Research

, Volume 11, Issue 12, pp 1742–1746

Effect of Current Magnitude and Drug Concentration on lontophoretic Delivery of Octreotide Acetate (Sandostatin®) in the Rabbit

  • David T.-W. Lau
  • John W. Sharkey
  • Lew Petryk
  • Frank A. Mancuso
  • Zhiling Yu
  • Francis L. S. Tse
Article

DOI: 10.1023/A:1018963300092

Cite this article as:
Lau, D.T., Sharkey, J.W., Petryk, L. et al. Pharm Res (1994) 11: 1742. doi:10.1023/A:1018963300092

Abstract

The effect of current magnitude and drug concentration on transdermal iontophoretic delivery of octreotide acetate (Sandostatin®) was examined in the rabbit. Plasma samples were collected over 24 hours and octreotide concentrations were determined by a radioimmunoassay. Without an electrical current, negligible plasma concentrations of octreotide were obtained. Following initiation of iontophoresis, plasma concentrations of octreotide increased rapidly, although did not sustain at a plateau level during the dosing period. Octreotide concentrations declined rapidly after removal of the device. Increasing the electrical current from 50 µA/cm2 to 150 µA/cm2 yielded a proportional increase in the delivery. Increasing the drug concentration in the device from 2.5 mg/mL to 5 mg/mL resulted in approximately proportional increase in plasma octreotide concentrations; however, further increase in plasma concentrations was not observed for drug concentrations beyond 5 mg/mL. lontophoretic delivery at the conditions which yielded the highest octreotide concentrations in this study (5 mg/mL solution at 150 µA/cm2 for 8 hours) yielded an apparent bioavailability (which represents an underestimate of the absolute bioavailability determined when the patches are run to exhaustion) of approximately 8%.

iontophoresisoctreotidetransdermalpeptiderabbit

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • David T.-W. Lau
    • 1
  • John W. Sharkey
    • 3
  • Lew Petryk
    • 1
  • Frank A. Mancuso
    • 3
  • Zhiling Yu
    • 1
  • Francis L. S. Tse
    • 1
  1. 1.Drug Metabolism and Pharmacokinetics Department, Drug Safety, Sandoz Research InstituteSandoz Pharmaceuticals CorporationEast Hanover
  2. 2.Department of Pharmacology, Amgen Inc.Thousand Oaks
  3. 3.Pharmacy Research Group, Technical R&D, Sandoz Research InstituteSandoz Pharmaceuticals CorporationEast Hanover